JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elalamy, I.
Right arrow Articles by Hatmi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elalamy, I.
Right arrow Articles by Hatmi, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 18, 13662-13667, May 5, 2000

Inhibition by Extracellular cAMP of Phorbol 12-Myristate 13-Acetate-induced Prostaglandin H Synthase-2 Expression in Human Pulmonary Microvascular Endothelial Cells
INVOLVEMENT OF AN ECTO-PROTEIN KINASE A ACTIVITY*

Ismaïl ElalamyDagger , Fatima Ait SaidDagger , Monique SingerDagger , Jean-Paul Couetil§, and Mohamed HatmiDagger

From the Dagger  Unité de Pharmacologie Cellulaire, Unité Associée Institut Pasteur-INSERM U 485, 25 rue du Dr. Roux, 75724 Paris Cedex 15 and the § Service de Chirurgie Cardio-thoracique, Hôpital Broussais, 75014 Paris, France

Exposure of human pulmonary microvascular endothelial cells (HPMECs) to phorbol 12-myristate 13-acetate (PMA) leads to the increase of prostaglandin H synthase (PGHS)-2 protein levels. Under same conditions and according to its constitutive nature, no significant variation of PGHS-1 protein was noted. The elevation of the intracellular cAMP rate is known to enhance PGHS-2 levels through a protein kinase A pathway in various cells. To determine whether the extracellular cAMP also regulates the inducible expression of PGHS, cultured HPMECs were exposed to cAMP alone or in combination with PMA. The PMA-induced PGHS-2 protein was attenuated by the extracellular cAMP. In addition, PGHS-2 activity evaluated through 6-keto-PGF1alpha generation, which was enhanced by PMA was inhibited by extracellular cAMP. Furthermore, in HPMEC medium, PMA-induced PGHS-2 expression was accompanied by the generation of a transferable activity (TA) able to abolish platelet aggregation. This resulting TA was dependent from PGHS-2 pathway, because NS-398, a selective inhibitor of PGHS-2, suppressed its production. The inhibitory TA released by treated HPMECs was also prevented by extracellular cAMP. The specific protein kinase A (PKA) inhibitor blocked the extracellular cAMP effect on both PMA-induced 6-keto-PGF1alpha synthesis and inhibitory TA generation, suggesting the involvement of PKA signaling at the outer surface of HPMECs. Accordingly, we established, in phosphorylation experiments, the presence of an endothelial ecto-protein kinase activity, able to phosphorylate the synthetic substrate kemptide in a cAMP-dependent mode. Reverse transcription-polymerase chain reaction analysis showed that PMA-induced PGHS-2 mRNA was markedly reduced by extracellular cAMP. Together, these findings provide the first experimental evidence that extracellular cAMP is able to reduce HPMEC PGHS-2 expression in terms of mRNA, protein, and enzyme activity through an ecto-PKA pathway. In addition, they outline the potential role of endothelial PGHS-2 in the limitation of platelet activation during inflammatory processes.


* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 33-1-40613659; Fax: 33-1-45688703; E-mail: mhatmi@pasteur.fr.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
PhysiologyHome page
A. M. Hofer and K. Lefkimmiatis
Extracellular Calcium and cAMP: Second Messengers as "Third Messengers"?
Physiology, October 1, 2007; 22(5): 320 - 327.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. S. Jung, H. Kubo, R. Wilson, S. R. Houser, and K. B. Margulies
Modulation of contractility by myocyte-derived arginase in normal and hypertrophied feline myocardium
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1756 - H1762.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. Bankir, M. Ahloulay, P. N. Devreotes, and C. A. Parent
Extracellular cAMP inhibits proximal reabsorption: are plasma membrane cAMP receptors involved?
Am J Physiol Renal Physiol, March 1, 2002; 282(3): F376 - F392.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. T. Davidge
Prostaglandin H Synthase and Vascular Function
Circ. Res., October 12, 2001; 89(8): 650 - 660.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.